Hepatitis B surface antigen-Spot (HBs Ag-Spot

HBsAg (hepatitis B surface antigen) indicates active hepatitis B virus infection. Its presence in blood shows the virus is replicating and the person is infectious; it appears in acute infection and, if detectable for more than six months, denotes chronic infection. HBsAg testing is used for diagnosis, monitoring, and screening blood donors and pregnant women to prevent transmission.

HBsAg positive means active hepatitis B infection. It may be acute (often mild or asymptomatic) or chronic (persistence >6 months). Chronic infection raises risk of cirrhosis, liver failure and liver cancer over years. Severity varies; evaluation (viral load, liver enzymes, imaging) and regular monitoring guide treatment. Antiviral therapy can suppress virus and reduce complications; vaccinate and test close contacts.

After a positive HBsAg result, clinicians confirm infection and determine acute versus chronic disease with repeat HBsAg, anti-HBc IgM, HBV DNA and HBeAg testing, plus liver function tests. They assess duration (more than six months indicates chronic), screen for HIV/HCV, evaluate transmission risk to contacts and pregnancy, counsel on infectivity, and refer for specialist care to consider monitoring or antiviral therapy.

Normal result for an HBsAg (hepatitis B surface antigen) test is a negative/non‑reactive result — i.e., HBsAg not detected. Some labs report quantitative values; typical assay thresholds consider <0.05 IU/mL (or signal‑to‑cutoff <1) as negative. A reactive/positive result indicates current hepatitis B infection and requires further evaluation and confirmatory testing by a clinician.

Management of HBsAg‑positive patients begins with staging: ALT, HBV DNA, HBeAg and fibrosis assessment (FibroScan/biopsy). Inactive carriers are monitored. Treat active disease or cirrhosis with potent nucleos(t)ide analogues (tenofovir or entecavir); pegylated interferon may be used selectively. Pregnant women with high viral load receive tenofovir in late pregnancy. Vaccinate and give HBIG to exposed contacts; avoid alcohol and hepatotoxins.

HBsAg positive generally indicates current hepatitis B virus infection (acute or chronic). However, transient positivity can occur shortly after vaccination, and false positives are possible. Additional tests—anti‑HBc IgM (acute), anti‑HBc total, HBeAg, and HBV DNA—help determine stage and infectivity. Clinical assessment and repeat testing are recommended; consult a healthcare provider for interpretation and management.